156 related articles for article (PubMed ID: 17190815)
21. Interleukin-1 receptor-associated kinase (IRAK) -1-mediated NF-kappaB activation requires cytosolic and nuclear activity.
Liu G; Park YJ; Abraham E
FASEB J; 2008 Jul; 22(7):2285-96. PubMed ID: 18276832
[TBL] [Abstract][Full Text] [Related]
22. Aberrant cytoplasmic localization of N-CoR in colorectal tumors.
Fernández-Majada V; Pujadas J; Vilardell F; Capella G; Mayo MW; Bigas A; Espinosa L
Cell Cycle; 2007 Jul; 6(14):1748-52. PubMed ID: 17630505
[TBL] [Abstract][Full Text] [Related]
23. [BAY11-7082 and Lactacystein in CD154-induced NF-kappaB activation].
Zhang X; Zhang W; Zeng XF; Zhang FC; Tang FL; Yu MX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):488-91. PubMed ID: 15562757
[TBL] [Abstract][Full Text] [Related]
24. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.
Carracedo A; Ma L; Teruya-Feldstein J; Rojo F; Salmena L; Alimonti A; Egia A; Sasaki AT; Thomas G; Kozma SC; Papa A; Nardella C; Cantley LC; Baselga J; Pandolfi PP
J Clin Invest; 2008 Sep; 118(9):3065-74. PubMed ID: 18725988
[TBL] [Abstract][Full Text] [Related]
26. Unraveling the Complex Interconnection between Specific Inflammatory Signaling Pathways and Mechanisms Involved in HIV-Associated Colorectal Oncogenesis.
Damane BP; Mulaudzi TV; Kader SS; Naidoo P; Savkovic SD; Dlamini Z; Mkhize-Kwitshana ZL
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765706
[TBL] [Abstract][Full Text] [Related]
27. The role of Hedgehog and Notch signaling pathway in cancer.
Xia R; Xu M; Yang J; Ma X
Mol Biomed; 2022 Dec; 3(1):44. PubMed ID: 36517618
[TBL] [Abstract][Full Text] [Related]
28. Targeting IKKα kinase to prevent tumor progression and therapy resistance.
Colomer C; Pecharroman I; Bigas A; Espinosa L
Cancer Drug Resist; 2020; 3(3):482-490. PubMed ID: 35582445
[TBL] [Abstract][Full Text] [Related]
29. Notch signaling pathway: architecture, disease, and therapeutics.
Zhou B; Lin W; Long Y; Yang Y; Zhang H; Wu K; Chu Q
Signal Transduct Target Ther; 2022 Mar; 7(1):95. PubMed ID: 35332121
[TBL] [Abstract][Full Text] [Related]
30. Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.
Buensuceso A; Fritz JL; Collins O; Valdés YR; Borrelli MJ; DiMattia GE; Shepherd TG
Sci Rep; 2022 Feb; 12(1):3011. PubMed ID: 35194062
[TBL] [Abstract][Full Text] [Related]
31. Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer.
Patel M; Pennel KAF; Quinn JA; Hood H; Chang DK; Biankin AV; Rebus S; Roseweir AK; Park JH; Horgan PG; McMillan DC; Edwards J
Br J Cancer; 2022 Jun; 126(12):1704-1714. PubMed ID: 35173303
[TBL] [Abstract][Full Text] [Related]
32. EPO activates PI3K-IKKα-CDK1 signaling pathway to promote the proliferation of Glial Cells under hypoxia environment.
Hu G; Wang T; Ma C
Genet Mol Biol; 2022; 45(1):e20210249. PubMed ID: 35167649
[TBL] [Abstract][Full Text] [Related]
33. IKKα Induces Epithelial-Mesenchymal Changes in Mouse Skin Carcinoma Cells That Can Be Partially Reversed by Apigenin.
García-García VA; Alameda JP; Page A; Mérida-García A; Navarro M; Tejero A; Paramio JM; García-Fernández RA; Casanova ML
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163299
[TBL] [Abstract][Full Text] [Related]
34. Targeting Notch to Maximize Chemotherapeutic Benefits: Rationale, Advanced Strategies, and Future Perspectives.
Zhdanovskaya N; Firrincieli M; Lazzari S; Pace E; Scribani Rossi P; Felli MP; Talora C; Screpanti I; Palermo R
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680255
[TBL] [Abstract][Full Text] [Related]
35. NF-κB-Dependent and -Independent (Moonlighting) IκBα Functions in Differentiation and Cancer.
Espinosa L; Marruecos L
Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572464
[TBL] [Abstract][Full Text] [Related]
36. A Review: Mechanism of
Saahene RO; Agbo E; Barnes P; Yahaya ES; Amoani B; Nuvor SV; Okyere P
Evid Based Complement Alternat Med; 2021; 2021():4514342. PubMed ID: 34484390
[No Abstract] [Full Text] [Related]
37. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway.
Kang W; Zhang J; Huang T; Zhou Y; Wong CC; Chan RCK; Dong Y; Wu F; Zhang B; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF
Oncogene; 2021 Mar; 40(9):1578-1594. PubMed ID: 33452458
[TBL] [Abstract][Full Text] [Related]
38. Targeting Notch in oncology: the path forward.
Majumder S; Crabtree JS; Golde TE; Minter LM; Osborne BA; Miele L
Nat Rev Drug Discov; 2021 Feb; 20(2):125-144. PubMed ID: 33293690
[TBL] [Abstract][Full Text] [Related]
39. Gibberellin JRA-003: A Selective Inhibitor of Nuclear Translocation of IKKα.
Annand JR; Henderson AR; Cole KS; Maurais AJ; Becerra J; Liu Y; Weerapana E; Koehler AN; Mapp AK; Schindler CS
ACS Med Chem Lett; 2020 Oct; 11(10):1913-1918. PubMed ID: 33062173
[TBL] [Abstract][Full Text] [Related]
40. CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation.
Chavdoula E; Habiel DM; Roupakia E; Markopoulos GS; Vasilaki E; Kokkalis A; Polyzos AP; Boleti H; Thanos D; Klinakis A; Kolettas E; Marcu KB
Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31792060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
